Open AccessRadioiodine therapy in patients with Graves′ disease and the effects of prior carbimazole therapy
Author(s) -
Arun Karyampudi,
Abdoul Hamide,
Dhanapathi Halanaik,
Jaya Prakash Sahoo,
Sadishkumar Kamalanathan
Publication year - 2014
Publication title -
indian journal of endocrinology and metabolism
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.456
H-Index - 28
eISSN - 2230-9500
pISSN - 2230-8210
DOI - 10.4103/2230-8210.139234
Subject(s) - carbimazole , medicine , graves' disease , radioiodine therapy , antithyroid drugs , disease , antithyroid agent , radioactive iodine , thyroid , thyroid cancer
The use of radioiodine as the first line of treatment in Graves' disease is restricted in India because of its limited availability and an unrealistic risk perception associated with it. Additionally, the effectiveness of radioiodine ablation in Graves' disease is influenced by many factors. Prior medical antithyroid therapy is one such important factor.